Clinical Validation
Clinical Validation - Related Videos
01:29
Reliability and Validity
0 Views •
2020
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways. Unfortunately, being consistent in measurement does not necessarily mean that you have measured something correctly. To illustrate this concept, consider a kitchen...
01:15
Data Validation
0 Views •
2024
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications. Key parameters for method validation include: Specificity: The ability of the method to accurately measure the target analyte without...
01:03
Data Validation
0 Views •
2023
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible. Nursing assessment guides are generally based on holistic models rather than medical...
09:00
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
0 Views •
Cited by 14 •
2012
High throughput validation of multiple candidate biomarkers can be performed by sequential ELISA in order to minimize freeze/thaw cycles and use of precious plasma samples. Here, we demonstrate how to sequentially perform ELISAs for six different validated plasma biomarkers1-3 of graft-versus-host disease (GVHD)4 on the same plasma sample.
07:50
Establishment of a Clinic-based Biorepository
0 Views •
Cited by 4 •
2017
Cutaneous tumors are often discarded following Mohs micrographic surgery. A protocol is described here that enables clinical support staff to effectively process and store cutaneous tumor (e.g., squamous cell carcinoma, basal cell carcinoma, and melanoma) samples for downstream laboratory applications without interfering with clinical operations.
FAQs
A reference standard or clinical endpoint provides a basis for judging whether results correspond to the condition or outcome being assessed. Comparing a test, biomarker, device, or intervention with that benchmark helps distinguish meaningful performance from technically promising results. This comparison supports consistent interpretation and strengthens decisions about diagnosis, treatment selection, risk assessment, or regulation.
These measures describe complementary qualities rather than a single overall score. Sensitivity and specificity characterize how results perform in relation to the assessed condition, while predictive value addresses the usefulness of a result in interpretation. Reproducibility examines whether performance remains consistent under defined conditions. Together, they show both accuracy-related behavior and reliability of the method.
Performance established in one group or setting may not fully represent results in another. Validation therefore examines the method under patient populations and conditions relevant to its intended use. This approach can reveal limitations that development or laboratory testing may not show, helping clinicians and decision-makers judge how confidently the evidence applies to patient care.
Laboratory or development results do not by themselves establish that a method will perform reliably during patient care. Clinical validation examines whether intended performance translates under defined clinical conditions and in relevant populations. That additional evidence connects technical or developmental findings with clinical usefulness, supporting more informed decisions about diagnosis, treatment, risk, safety, and regulation.
A typical assessment identifies the intended medical use, selects relevant patients and clinical conditions, and compares the method with an accepted reference standard or clinical endpoint. Investigators then examine measures such as sensitivity, specificity, predictive value, safety, and reproducibility. The resulting evidence is interpreted to determine usefulness, reliability, limitations, and suitability for clinical or regulatory decisions.
Researchers use it when evidence is needed to determine whether a medical method performs as intended in patient care. The assessment can inform evidence-based diagnosis, treatment selection, risk assessment, and regulatory decisions. It is especially relevant when moving beyond laboratory or development findings, because patient-based evidence can demonstrate practical usefulness while identifying performance limitations.
It can show whether performance is reliable, safe, reproducible, and clinically useful under defined conditions. Validation may also identify limitations associated with particular patient populations or clinical contexts. These findings help determine how much confidence to place in results and whether the method supports patient-care decisions or regulatory evaluation rather than merely producing technically plausible measurements.